Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cvrx Inc (CVRX)

Cvrx Inc (CVRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cvrx Inc 9201 WEST BROADWAY AVENUE SUITE 650 MINNEAPOLIS MN 55445 USA

www.cvrx.com Employees: 223 P: 763-416-2840 F: 763-416-2841

Sector:

Medical

Description:

CVRx Inc. is a commercial-stage medical device company. It focused on developing, manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx Inc. is headquartered in Minneapolis, MN.

Key Statistics

Overview:

Market Capitalization, $K 196,814
Enterprise Value, $K 170,614
Shares Outstanding, K 26,312
Float, K 22,655
% Float 86.10%
Short Interest, K 1,693
Short Float 6.43%
Days to Cover 7.77
Short Volume Ratio 0.38
% of Insider Shareholders 13.90%
% of Institutional Shareholders 75.27%

Financials:

Annual Sales, $ 56,650 K
Annual Net Income, $ -53,310 K
Last Quarter Sales, $ 16,020 K
Last Quarter Net Income, $ -11,930 K
EBIT, $ -51,270 K
EBITDA, $ -50,270 K

Growth:

1-Year Return 19.67%
3-Year Return -22.93%
5-Year Return 0.00%
5-Year Revenue Growth 836.36%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.46 on 02/12/26
Next Earnings Date 05/14/26 [--]
Earnings Per Share ttm -2.05
EPS Growth vs. Prev Qtr 6.12%
EPS Growth vs. Prev Year -6.98%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CVRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -99.33%
Return-on-Assets % -45.83%
Profit Margin % -94.10%
Debt/Equity 1.26
Price/Sales 3.59
Price/Cash Flow N/A
Price/Book 5.15
Book Value/Share 1.50
Interest Coverage -8.15
60-Month Beta 1.16
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.